tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CDTX Stock Latest News

Cidara Therapeutics price target raised to $69 from $68 at Guggenheim
The FlyCidara Therapeutics price target raised to $69 from $68 at Guggenheim
2d ago
CDTX
Cidara Therapeutics announces inclusion in Russell 2000, 3000 Indexes
PremiumThe Fly
Cidara Therapeutics announces inclusion in Russell 2000, 3000 Indexes
10d ago
CDTX
Cidara Therapeutics Announces $350 Million Stock Offering
PremiumCompany Announcements
Cidara Therapeutics Announces $350 Million Stock Offering
15d ago
8K
CDTX
Cidara Therapeutics 7.95M share Secondary priced at $44.00
PremiumThe Fly
Cidara Therapeutics 7.95M share Secondary priced at $44.00
16d ago
CDTX
Cidara Therapeutics Suspends ATM Prospectus with Jefferies
PremiumCompany Announcements
Cidara Therapeutics Suspends ATM Prospectus with Jefferies
16d ago
8K
CDTX
Cidara Therapeutics price target raised to $68 from $50 at Guggenheim
PremiumThe FlyCidara Therapeutics price target raised to $68 from $50 at Guggenheim
17d ago
CDTX
Cidara Therapeutics price target raised to $75 from $35 at RBC Capital
Premium
The Fly
Cidara Therapeutics price target raised to $75 from $35 at RBC Capital
17d ago
CDTX
Why Is Cidara Therapeutics Stock (CDTX) Up 80% Today?
Premium
Market News
Why Is Cidara Therapeutics Stock (CDTX) Up 80% Today?
17d ago
CDTX
Cidara Therapeutics announces $250M common stock offering
PremiumThe Fly
Cidara Therapeutics announces $250M common stock offering
17d ago
CDTX
Cidara Therapeutics Reports Positive Phase 2b Trial Results
PremiumCompany Announcements
Cidara Therapeutics Reports Positive Phase 2b Trial Results
17d ago
8K
CDTX
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
17d ago
ACN
AMD
Cidara Therapeutics price target raised to $53 from $41 at H.C. Wainwright
PremiumThe Fly
Cidara Therapeutics price target raised to $53 from $41 at H.C. Wainwright
17d ago
CDTX
U.S. strikes Iran nuclear sites, Novo terminates Hims & Hers deal: Morning Buzz
PremiumThe FlyU.S. strikes Iran nuclear sites, Novo terminates Hims & Hers deal: Morning Buzz
17d ago
BK
AMD
Cidara Therapeutics price target raised to $75 from $35 at RBC Capital
Premium
The Fly
Cidara Therapeutics price target raised to $75 from $35 at RBC Capital
17d ago
CDTX
Cidara says Phase 2b NAVIGATE TRIAL met primary, secondary efficacy endpoints
Premium
The Fly
Cidara says Phase 2b NAVIGATE TRIAL met primary, secondary efficacy endpoints
17d ago
CDTX
Cidara Therapeutics Approves Key Amendments at Annual Meeting
PremiumCompany Announcements
Cidara Therapeutics Approves Key Amendments at Annual Meeting
20d ago
8K
CDTX
Cidara Therapeutics assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Cidara Therapeutics assumed with a Buy at H.C. Wainwright
23d ago
CDTX
Optimistic Buy Rating for Cidara Therapeutics Ahead of Phase 2b Flu Trial Results
PremiumRatings
Optimistic Buy Rating for Cidara Therapeutics Ahead of Phase 2b Flu Trial Results
1M ago
CDTX
Strong Buy Rating for Cidara Therapeutics: CD388’s Revolutionary Potential in Flu Treatment and Beyond
PremiumRatings
Strong Buy Rating for Cidara Therapeutics: CD388’s Revolutionary Potential in Flu Treatment and Beyond
1M ago
CDTX
Cidara Therapeutics price target raised to $35 from $31 at RBC Capital
PremiumThe FlyCidara Therapeutics price target raised to $35 from $31 at RBC Capital
2M ago
CDTX
Cidara Therapeutics price target raised to $50 from $35 at Guggenheim
Premium
The Fly
Cidara Therapeutics price target raised to $50 from $35 at Guggenheim
2M ago
CDTX
Promising Developments and Upcoming Data Release Drive Buy Rating for Cidara Therapeutics
Premium
Ratings
Promising Developments and Upcoming Data Release Drive Buy Rating for Cidara Therapeutics
2M ago
CDTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >